LSE - Delayed Quote • GBp
Genus plc (GNS.L)
At close: April 19 at 4:35 PM GMT+1
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
673,100.00
689,700.00
593,400.00
574,300.00
551,400.00
Cost of Revenue
329,600.00
450,400.00
378,200.00
357,500.00
329,600.00
Gross Profit
221,800.00
239,300.00
215,200.00
216,800.00
221,800.00
Operating Expense
155,000.00
195,300.00
163,800.00
165,800.00
160,200.00
Operating Income
50,600.00
44,000.00
51,400.00
51,000.00
61,600.00
Net Non Operating Interest Income Expense
-5,000.00
-14,300.00
-6,200.00
-5,000.00
-5,000.00
Pretax Income
38,700.00
39,400.00
48,400.00
55,800.00
46,300.00
Tax Provision
10,600.00
7,600.00
11,700.00
9,000.00
10,600.00
Net Income Common Stockholders
33,400.00
33,300.00
40,900.00
47,300.00
35,300.00
Diluted NI Available to Com Stockholders
33,400.00
33,300.00
40,900.00
47,300.00
35,300.00
Basic EPS
0.51
0.51
0.62
0.73
0.54
Diluted EPS
0.51
0.51
0.62
0.72
0.54
Basic Average Shares
65,627.00
65,557.00
65,395.00
65,108.00
64,908.00
Diluted Average Shares
66,107.50
65,988.00
65,714.00
65,662.00
65,427.00
Total Operating Income as Reported
47,100.00
40,500.00
49,400.00
47,700.00
42,400.00
Rent Expense Supplemental
1,200.00
100.00
100.00
100.00
1,200.00
Total Expenses
484,600.00
645,700.00
542,000.00
523,300.00
489,800.00
Net Income from Continuing & Discontinued Operation
33,400.00
33,300.00
40,900.00
47,300.00
35,300.00
Normalized Income
36,235.00
36,023.00
42,414.00
49,926.80
49,412.00
Interest Income
3,200.00
1,100.00
400.00
400.00
300.00
Interest Expense
19,200.00
14,300.00
5,700.00
4,500.00
4,900.00
Net Interest Income
-5,000.00
-14,300.00
-6,200.00
-5,000.00
-5,000.00
EBIT
57,900.00
53,700.00
54,100.00
60,300.00
51,200.00
EBITDA
103,000.00
97,300.00
93,100.00
95,400.00
88,300.00
Reconciled Cost of Revenue
329,600.00
450,400.00
378,200.00
357,500.00
329,600.00
Reconciled Depreciation
45,100.00
43,600.00
39,000.00
35,100.00
37,100.00
Net Income from Continuing Operation Net Minority Interest
33,400.00
33,300.00
40,900.00
47,300.00
35,300.00
Total Unusual Items Excluding Goodwill
-3,500.00
-3,500.00
-2,000.00
-3,300.00
-19,200.00
Total Unusual Items
-3,500.00
-3,500.00
-2,000.00
-3,300.00
-19,200.00
Normalized EBITDA
106,500.00
100,800.00
95,100.00
98,700.00
107,500.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-665.00
-777.00
-486.00
-673.20
-5,088.00
6/30/2020 - 7/6/2000
Yahoo Finance Plus Essential access required. Unlock Access
Related Tickers
IBT-B.ST Infant Bacterial Therapeutics AB (publ)
84.40
-3.43%
VICO.ST Vicore Pharma Holding AB (publ)
16.32
+1.49%
ADXN.SW Addex Therapeutics Ltd
0.1505
-5.64%
PRTC.L PureTech Health plc
206.50
-0.48%
VVY.AS Vivoryon Therapeutics N.V.
0.4530
-3.62%
EVE.SW Evolva Holding SA
0.9420
-5.80%
ACE.ST Ascelia Pharma AB (publ)
13.18
-5.04%
BINV.ST BioInvent International AB (publ)
23.70
-1.04%
CAMX.ST Camurus AB (publ)
485.00
+2.41%
BSLN.SW Basilea Pharmaceutica AG
40.75
-2.86%